LNA Santé

Dividend History: Eleven Consecutive Years of Payments

Since its IPO in June 2006, LNA Santé has established a strong track record as a consistent dividend-paying company. The table below sets out the dividends paid since the 2015 financial year. Amounts are expressed per financial year ending 31 December, with payment generally taking place during the following summer after approval by the Annual General Meeting.

* The 2020 dividend was significantly reduced due to the COVID-19 pandemic. Nevertheless, the Company maintained its dividend, demonstrating its commitment to preserving a long-term relationship with shareholders

Financial Year
Dividend per Share
2025
0,95 €
2024
0,65 €
2023
0,60 €
2022
0,50 €
2021
0,43 €
2020*
0,20 €
2019
0,45 €
2018
0,38 €
2017
0,32 €
2016
0,23 €
2015
0,16 €
Financial publications and documents

Dividend Growth at a Glance

  • €0.16 (FY2015) → €0.95 (FY2025)
  • Continuous dividend growth since 2021: from €0.43 to €0.95 in four years
  • No interruption in dividend payments for more than ten years

Key takeaway

The dividend for FY2025 amounts to €0.95 per share, compared with €0.65 for FY2024. The increase reflects the Company's earnings growth over the period and is scheduled to be paid in July 2026.

The Financial Indicators Supporting the Dividend

A reliable dividend is only meaningful when it is backed by solid financial fundamentals. Three key indicators deserve particular attention.

Payout Ratio: A Conservative Distribution Policy

LNA Santé distributes approximately 30% of its FY2025 net income as dividends. This conservative payout ratio is broadly in line with that of comparable listed companies that pay dividends.

Such a policy sends a positive signal: the Company rewards shareholders while retaining sufficient financial resources to fund future growth, reduce debt and pursue selective acquisition opportunities. Conversely, an excessively high payout ratio could indicate greater financial vulnerability.

Financial Leverage: Significant Headroom

As of 31 December 2025, operating debt stood at €107 million, corresponding to an Operating Leverage ratio of 1.4x.

This level remains well below the 4.25x covenant agreed with LNA Santé's banking partners, providing substantial financial flexibility and supporting the Company's ability to maintain dividend payments even during periods of economic uncertainty.

Free Cash Flow Coverage

With a cash payout ratio below 10%, the dividend is comfortably covered by free cash flow generation.

Ultimately, sustainable dividends are supported by cash generation rather than accounting profits. LNA Santé distributes only a small proportion of the cash it generates, reinforcing the long-term sustainability of its dividend policy.

Three Key Financial Indicators

  • Payout ratio : approximately 30% of net income

  • Operating Leverage : 1.4x as of 31 December 2025 (bank covenant: 4.25x)
  • Cash payout ratio : below 10% of free cash flow

Governance aligned with the long term

LNA Santé’s dividend policy is closely linked to its shareholder structure. More than 60% of the company’s voting rights are held by its founding families, executives and employees. Regular dividend distributions therefore contribute to preserving this long-term ownership and governance structure, notably by enabling these shareholders to meet their financing obligations.

A stable core shareholder base

La répartition du capital de LNA Santé présente une configuration rare parmi les sociétés cotées de taille comparable :

  • The founding families, united around the entrepreneur who has led the project since its inception, hold more than 30% of the voting rights. Their continued presence in the company’s capital since its IPO in 2006 reflects a strategy built for the long term.
  • More than 2,500 LNA Santé professionals collectively hold nearly 10% of the share capital. This employee share ownership, which has grown significantly since 2022, reflects strong collective commitment and a natural alignment between the interests of employees and shareholders.
  • Overall, the founding families, executives, long-standing partners and employees represent more than 60% of the voting rights and more than 50% of the share capital. This structure safeguards LNA Santé’s independence and supports the continuity of its strategic direction.

Double voting rights: rewarding long-term shareholders

LNA Santé grants double voting rights automatically to all registered shares held for at least two years. In practical terms, an individual shareholder who holds registered shares for two years sees their voting power at General Meetings double. This is LNA Santé’s way of rewarding shareholder loyalty and aligning individual share ownership with the company’s long-term perspective.

LNA Santé’s shareholder structure

For every LNA Santé shareholder, this means investing in a company driven by committed women and men who are dedicated to the consistency of their corporate project and to creating sustainable value while addressing a major societal challenge.

FAQ

Frequently asked questions

The dividend paid in respect of the 2025 financial year amounts to €0.95 per share, compared with €0.65 for the 2024 financial year. This increase primarily reflects growth in earnings over the period. The payout ratio remains at around 30% of net income, a conservative level that supports the sustainability of the dividend over the long term.

Have any other questions? Contact us.

In Summary

LNA Santé offers a distinctive dividend profile among listed small and mid-cap healthcare companies: eleven consecutive years of dividend payments, a conservative payout ratio supporting the sustainability of future distributions, financial leverage well below banking covenant thresholds, and a governance structure in which decision-makers share the same long-term interests as minority shareholders.

Take Action

LNA Santé Investor Relations
Results, shareholding structure and regulatory publications
Shareholder Information
Gouvernance, actionnariat, fiche signalétique
French Financial Markets Authority (AMF)
Official filings and reference documents

This content is provided for informational purposes only and does not constitute investment advice. Any investment decision should be made after consulting a qualified professional. Past performance is not indicative of future results.